Moreover, the inhibition of UBE2C promoted Parkin‐mediated K63‐linked ubiquitination of TOP2A, leading to its proteasomal degradation and thus sensitizing breast cancer cells to doxorubicin. This evidence concerns the gene PRKN and breast cancer.